Literature DB >> 18454794

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.

Karin S Coyne1, Chris C Sexton, Debra E Irwin, Zoe S Kopp, Con J Kelleher, Ian Milsom.   

Abstract

OBJECTIVES: To examine the effect overactive bladder (OAB) and other lower urinary tract symptoms (LUTS) on health-related quality of life (HRQoL) in a population sample, as OAB often occurs in conjunction with many other LUTS. SUBJECTS AND METHODS: A nested case-control analysis was performed on men and women with (cases) and without (controls) OAB, from the EPIC study. OAB was assessed using 2002 International Continence Society definitions. Based on their responses to questions about LUTS, cases were classified into five groups; continent OAB, OAB with incontinence, OAB + postmicturition, OAB + voiding, and OAB + postmicturition + voiding. Both cases and controls were asked questions about symptom bother (OAB-q), generic QoL (EQ-5D), work productivity (Work Productivity and Activity Impairment, WPAI), depressive symptoms (Center for Epidemiologic Studies Depression Scale), sexual satisfaction, and erectile dysfunction (men only) using the Massachusetts Male Aging Study. Cases answered additional condition-specific questions HRQoL (OAB-q short form), Patient Perception of Bladder Condition and work productivity related to a specific health problem (WPAI-SHP). General linear models were used to evaluate group differences.
RESULTS: Of the EPIC participants, 1434 identified OAB cases were matched by age, gender and country, with 1434 participants designated as controls. Cases and controls were primarily Caucasian (96.2% and 96.7%, respectively), and most (65%) were female; the mean age was 53.8 and 53.7 years, respectively. Comorbid conditions differed significantly by case/control status, with cases reporting significantly greater rates of chronic constipation, asthma, diabetes, high blood pressure, bladder or prostate cancer, neurological conditions and depression. There were significant differences between the cases and controls in all reported LUTS. The OAB + postmicturition + voiding group reported significantly greater symptom bother, worse HRQoL, higher rates of depression and decreased enjoyment of sexual activity, than the other subgroups.
CONCLUSION: OAB has a substantial, multidimensional impact on patients; OAB with additional LUTS has a greater impact. The diagnosis and treatment of OAB should be considered in conjunction with other LUTS, to maximize treatment options and optimize patient outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18454794     DOI: 10.1111/j.1464-410X.2008.07601.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  209 in total

1.  Prevalence and predictors of overactive bladder in nonpregnant nulliparous women below 65 years of age.

Authors:  Dudley Robinson; Sigvard Åkervall; Adrian Wagg; Christopher Chapple; Ian Milsom; Maria Gyhagen
Journal:  Int Urogynecol J       Date:  2017-08-04       Impact factor: 2.894

2.  Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Authors:  Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay
Journal:  Eur J Clin Pharmacol       Date:  2011-12-04       Impact factor: 2.953

3.  Can we predict and prevent pelvic floor dysfunction?

Authors:  Ian Milsom
Journal:  Int Urogynecol J       Date:  2015-12       Impact factor: 2.894

4.  Economic evaluation of sacral neuromodulation in overactive bladder: A Canadian perspective.

Authors:  Magdy M Hassouna; Hamid Sadri
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

5.  Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies.

Authors:  Peter K Sand; John Heesakkers; Stephen R Kraus; Martin Carlsson; Zhonghong Guan; Sandra Berriman
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

6.  The effect of pelvic pain and urinary incontinence on women's self-rated health in northern Mexico.

Authors:  Hilda García-Pérez; Sioban D Harlow; Catalina Denman
Journal:  Int Urogynecol J       Date:  2018-01-08       Impact factor: 2.894

7.  Association between urinary incontinence and depressive symptoms in overweight and obese women.

Authors:  Vivian W Sung; Delia S West; Alexandra L Hernandez; Thomas L Wheeler; Deborah L Myers; Leslee L Subak
Journal:  Am J Obstet Gynecol       Date:  2009-02-23       Impact factor: 8.661

8.  The Spectrum of Bladder Health: The Relationship Between Lower Urinary Tract Symptoms and Interference with Activities.

Authors:  Siobhan Sutcliffe; Tamara Bavendam; Charles Cain; C Neill Epperson; Colleen M Fitzgerald; Sheila Gahagan; Alayne D Markland; David A Shoham; Ariana L Smith; Mary K Townsend; Kyle Rudser
Journal:  J Womens Health (Larchmt)       Date:  2019-05-06       Impact factor: 2.681

Review 9.  Female Pelvic Medicine and Reconstructive Surgery-What Does Certification Mean?

Authors:  Steven J Weissbart; Alan J Wein; Ariana L Smith
Journal:  Curr Urol Rep       Date:  2018-03-19       Impact factor: 3.092

10.  What is the ideal antibiotic prophylaxis for intravesically administered Botox injection? A comparison of two different regimens.

Authors:  Justin Houman; Ariel Moradzadeh; Devin N Patel; Kian Asanad; Jennifer T Anger; Karyn S Eilber
Journal:  Int Urogynecol J       Date:  2018-08-03       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.